ArticleTherapeutic advances in neurological disorders2018

Incidence and mitigation of gastrointestinal events in patients with relapsing-remitting multiple sclerosis receiving delayed-release dimethyl fumarate: a German phase IV study (TOLERATE).

Ralf Gold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.